166 related articles for article (PubMed ID: 31780441)
1. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy.
Terao N; Koizumi H; Kojima K; Kusada N; Nagata K; Yamagishi T; Yoneda K; Yoshii K; Kinoshita S; Sotozono C
Br J Ophthalmol; 2020 Sep; 104(9):1260-1265. PubMed ID: 31780441
[TBL] [Abstract][Full Text] [Related]
2. Biometric characteristics of eyes with central serous chorioretinopathy.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
4. Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging.
Balaratnasingam C; Freund KB; Tan AM; Mrejen S; Hunyor AP; Keegan DJ; Dansingani KK; Dayani PN; Barbazetto IA; Sarraf D; Jampol LM; Yannuzzi LA
Ophthalmology; 2016 Jul; 123(7):1541-52. PubMed ID: 27084564
[TBL] [Abstract][Full Text] [Related]
5. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
Pang CE; Shah VP; Sarraf D; Freund KB
Am J Ophthalmol; 2014 Aug; 158(2):362-371.e2. PubMed ID: 24794091
[TBL] [Abstract][Full Text] [Related]
6. POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY: Pachychoroid Spectrum of Diseases.
Manayath GJ; Shah VS; Saravanan VR; Narendran V
Retina; 2018 Jun; 38(6):1195-1204. PubMed ID: 28445211
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
8. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
9. Indocyanine green angiography in chronic central serous chorioretinopathy.
Gajdzik-Gajdecka U; Dorecka M; Nita E; Michalska A; Miniewicz-Kurowska J; Romaniuk W
Med Sci Monit; 2012 Feb; 18(2):CR51-57. PubMed ID: 22293877
[TBL] [Abstract][Full Text] [Related]
10. The expanded spectrum of focal choroidal excavation.
Margolis R; Mukkamala SK; Jampol LM; Spaide RF; Ober MD; Sorenson JA; Gentile RC; Miller JA; Sherman J; Freund KB
Arch Ophthalmol; 2011 Oct; 129(10):1320-5. PubMed ID: 21670327
[TBL] [Abstract][Full Text] [Related]
11. Dilatation of Asymmetric Vortex Vein in Central Serous Chorioretinopathy.
Hiroe T; Kishi S
Ophthalmol Retina; 2018 Feb; 2(2):152-161. PubMed ID: 31047342
[TBL] [Abstract][Full Text] [Related]
12. Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy.
Terao N; Imanaga N; Wakugawa S; Sawaguchi S; Tamashiro T; Yamauchi Y; Koizumi H
Ophthalmol Sci; 2021 Dec; 1(4):100071. PubMed ID: 36246946
[TBL] [Abstract][Full Text] [Related]
13. Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy.
Mrejen S; Balaratnasingam C; Kaden TR; Bottini A; Dansingani K; Bhavsar KV; Yannuzzi NA; Patel S; Chen KC; Yu S; Stoffels G; Spaide RF; Freund KB; Yannuzzi LA
Ophthalmology; 2019 Apr; 126(4):576-588. PubMed ID: 30659849
[TBL] [Abstract][Full Text] [Related]
14. Effect of Serous Retinal Detachment on the Measurement of Axial Length in Central Serous Chorioretinopathy.
Shin YI; Won YK; Shin KS; Jo YJ; Kim JY
Korean J Ophthalmol; 2019 Feb; 33(1):63-69. PubMed ID: 30746913
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
[TBL] [Abstract][Full Text] [Related]
16. Combined central serous chorioretinopathy, hypermetropia, short axial length, chorioretinal folds, enlarged/thickened ocular coats, with varying association of scleral changes (CHAFES).
Downes SM; Mall SP; Al-Khuzaei S; Chadha R; Gibson A; Chong V; Bird AC
BMC Ophthalmol; 2023 Jul; 23(1):322. PubMed ID: 37452273
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy].
Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT
Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240
[TBL] [Abstract][Full Text] [Related]
19. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
Song IS; Shin YU; Lee BR
Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
[TBL] [Abstract][Full Text] [Related]
20. Abnormal choroidal flow on optical coherence tomography angiography in central serous chorioretinopathy.
Seo EJ; Um T; Yoon YH
Clin Exp Ophthalmol; 2019 May; 47(4):505-512. PubMed ID: 30515936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
